Search research articles
Contact Us
Filters
Showing results (81-90 of 160) with videos related to
Page
of 16
Sort By:
International Archives of Occupational and Environmental Health
|
October 1, 2013
Biological monitoring and health effects of low-level exposure to N-methyl-2-pyrrolidone: a cross-sectional study
Vincent Haufroid, Veronika K Jaeger, Stefan Jeggli, et al.
Expert Opinion on Drug Metabolism & Toxicology
|
July 30, 2020
Predictors of tacrolimus pharmacokinetic variability: current evidences and future perspectives
Alexandra L Degraeve, Serge Moudio, Vincent Haufroid, et al.
Frontiers in Pharmacology
|
October 8, 2024
Case report: A case of severe capecitabine toxicity due to confirmed in trans compound heterozygosity of a common and rare DPYD variant
Amy de Haar-Holleman, Pieter-Jan Cortoos, Jelle Vlaeminck, et al.
Pharmacogenomics
|
September 10, 2011
Effect of a new functional CYP3A4 polymorphism on calcineurin inhibitors' dose requirements and trough blood levels in stable renal transplant patients
Laure Elens, Ron H van Schaik, Nadtha Panin, et al.
Therapeutic Drug Monitoring
|
October 17, 2022
Genetic Polymorphisms in SLCO2B1 and ABCC1 Conjointly Modulate Atorvastatin Intracellular Accumulation in HEK293 Recombinant Cell Lines
Emilia Hoste, Adrien Paquot, Nadtha Panin, et al.
Microbiome
|
July 5, 2023
Gut microbiome modulates tacrolimus pharmacokinetics through the transcriptional regulation of ABCB1
Alexandra L Degraeve, Vincent Haufroid, Axelle Loriot, et al.
Scientific Reports
|
May 11, 2018
Impact of UGT1A1 polymorphisms on Raltegravir and its glucuronide plasma concentrations in a cohort of HIV-1 infected patients
Leïla Belkhir, Carole Seguin-Devaux, Laure Elens, et al.
Environmental Health Perspectives
|
June 19, 2013
Associations of urinary cadmium with age and urinary proteins: further evidence of physiological variations unrelated to metal accumulation and toxicity
Agnes Chaumont, Catherine Voisin, Gladys Deumer, et al.
Clinical Chemistry and Laboratory Medicine
|
June 19, 2024
Can we identify patients carrying targeted deleterious <i>DPYD</i> variants with plasma uracil and dihydrouracil? A GPCO-RNPGx retrospective analysis
Manon Launay, Laure Raymond, Jérôme Guitton, et al.
International Archives of Occupational and Environmental Health
|
November 15, 2008
Evaluation of urinary biomarkers of exposure to benzene: correlation with blood benzene and influence of confounding factors
Perrine Hoet, Erika De Smedt, Massimo Ferrari, et al.
Page
of 16
Search research articles
Search
Showing results (81-90 of 160) with videos related to
Sort By:
Page
of 16
International Archives of Occupational and Environmental Health
|
October 1, 2013
Biological monitoring and health effects of low-level exposure to N-methyl-2-pyrrolidone: a cross-sectional study
Vincent Haufroid, Veronika K Jaeger, Stefan Jeggli, et al.
Expert Opinion on Drug Metabolism & Toxicology
|
July 30, 2020
Predictors of tacrolimus pharmacokinetic variability: current evidences and future perspectives
Alexandra L Degraeve, Serge Moudio, Vincent Haufroid, et al.
Frontiers in Pharmacology
|
October 8, 2024
Case report: A case of severe capecitabine toxicity due to confirmed in trans compound heterozygosity of a common and rare DPYD variant
Amy de Haar-Holleman, Pieter-Jan Cortoos, Jelle Vlaeminck, et al.
Pharmacogenomics
|
September 10, 2011
Effect of a new functional CYP3A4 polymorphism on calcineurin inhibitors' dose requirements and trough blood levels in stable renal transplant patients
Laure Elens, Ron H van Schaik, Nadtha Panin, et al.
Therapeutic Drug Monitoring
|
October 17, 2022
Genetic Polymorphisms in SLCO2B1 and ABCC1 Conjointly Modulate Atorvastatin Intracellular Accumulation in HEK293 Recombinant Cell Lines
Emilia Hoste, Adrien Paquot, Nadtha Panin, et al.
Microbiome
|
July 5, 2023
Gut microbiome modulates tacrolimus pharmacokinetics through the transcriptional regulation of ABCB1
Alexandra L Degraeve, Vincent Haufroid, Axelle Loriot, et al.
Scientific Reports
|
May 11, 2018
Impact of UGT1A1 polymorphisms on Raltegravir and its glucuronide plasma concentrations in a cohort of HIV-1 infected patients
Leïla Belkhir, Carole Seguin-Devaux, Laure Elens, et al.
Environmental Health Perspectives
|
June 19, 2013
Associations of urinary cadmium with age and urinary proteins: further evidence of physiological variations unrelated to metal accumulation and toxicity
Agnes Chaumont, Catherine Voisin, Gladys Deumer, et al.
Clinical Chemistry and Laboratory Medicine
|
June 19, 2024
Can we identify patients carrying targeted deleterious <i>DPYD</i> variants with plasma uracil and dihydrouracil? A GPCO-RNPGx retrospective analysis
Manon Launay, Laure Raymond, Jérôme Guitton, et al.
International Archives of Occupational and Environmental Health
|
November 15, 2008
Evaluation of urinary biomarkers of exposure to benzene: correlation with blood benzene and influence of confounding factors
Perrine Hoet, Erika De Smedt, Massimo Ferrari, et al.
Page
of 16